Posts Tagged ‘CCRM’

Right Turn: This is us

Author: Stacey Johnson, 10/13/17

If you’ve stumbled upon this blog thinking you will be reading about the attractive and talented cast of the popular 2016 TV show on NBC, I suspect you will be very disappointed. While there is video for you below, you will not see any rippling muscles and you don’t need to have any tissues handy…Read more

Right Turn: Immortalizing excellence in stem cell research

Author: Stacey Johnson, 09/29/17

In some circles, James Till needs no introduction. Along with Ernest McCulloch (deceased), Dr. Till advanced medical research across the globe with the discovery of blood stem cells[1][2] at Toronto’s Princess Margaret Hospital, now the Princess Margaret Cancer Centre. Yesterday, outside the MaRS Discovery District in downtown Toronto, during a grand opening event for CCRM,…Read more

BRM2017: State of the regenerative medicine industry

Author: Stacey Johnson, 08/09/17

Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His graduate research at Queen’s University, where he is pursuing a PhD in Chemical…Read more

Right Turn: Primers on cell therapy regulation

Author: Stacey Johnson, 06/16/17

Understanding cell therapy regulation is an essential component of the bench to bedside pipeline. Without approval from a country’s regulator (Health Canada, FDA, EMA, PMDA, etc.), a product cannot be sold to consumers and the millions invested in research and development, manufacturing and clinical trials is media down the drain. Cell therapies present a range…Read more

Five regenerative medicine workshops to attend this summer

Author: Guest, 05/15/17

Amin Adibi is a biomedical engineer and a health data analyst at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for…Read more

Right Turn: Toronto’s ‘Willy Wonka’ Could Have Worked at CCRM

Author: Stacey Johnson, 05/05/17

Everyone has a story of how they ended up in their career. My lightbulb moment happened when I was in fourth year at university, thankfully, which gave me a plan upon graduation. I was thinking about this yesterday when a large group of NSERC CREATE students (and some profs) visited CCRM to learn what we…Read more

Right Turn: The robots aren’t coming, they’re here

Author: Stacey Johnson, 03/31/17

via GIPHY Artificial Intelligence (AI) already permeates our culture and that’s only going to increase with time and advances to the technology. Some think this is good news, progress and inevitable while others, like Stephen Hawking for example, fear where AI could take us. AI is on my mind this week with the announcement that…Read more

Right Turn: Rare sighting of Macareindeer captured on video before holidays

Author: Stacey Johnson, 12/23/16

Our story begins in a wondrous land called Torona, far from the North Pole, where mythical creatures – half human, half reindeer – have dedicated their adult years to the admirable pursuit of helping to treat patients around the world with “regenerative medicines,” whether they’ve been naughty or nice. When they aren’t busy with their…Read more

Insights from CGTW16 – Part 1: Cell Manufacturing Best Practices

Author: Guest, 11/17/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more

Special op/ed: Canada can lead the world in regenerative medicine — but it won’t happen without strategic investment

Author: Michael May, 08/30/16

Michael May is President and CEO of CCRM, a leader in developing and commercializing regenerative medicine, cell and gene therapy technologies, Michael Rudnicki is Scientific Director and CEO of Stem Cell Network, with a mandate to translate stem cell research into clinical applications, commercial products and public policy, and Peter Zandstra is a professor in…Read more